Page 211 - 先天性心脏病的导管术:从婴幼儿期到成人期
P. 211

18 复合方式                                                                   193


                       infants and children. Heart. 1973;35(6):643-6. http://heart.bmj.com/cgi/doi/10.1136/

                       hrt.35.6.643
                   [8]  Dimas VV, Leonard SR, Guleserian KJ, Forbess JM, Zellers TM. Stent implantation
                       for coarctation of the aorta in a premature infant through carotid cutdown as a bridge to
                       surgical correction. J Thorac Cardiovasc Surg. 2010;139(4):1070-1. https://linkinghub.

                       elsevier.com/retrieve/pii/S0022522309003511
                   [9]  Ligon RA, Kim DW, Vincent RN, Bauser-Heaton HD, Ooi YK, Petit CJ. Angiographic
                       follow-up of infants and children undergoing percutaneous carotid artery interventions.
                       Catheter Cardiovasc Interv. 2018;91(7):1301-6. http://doi.wiley.com/10.1002/ccd.27481

                   [10] Mylotte D, Sudre A, Teiger E, Obadia JF, Lee M, Spence M, et al. transcarotid tran-
                       scatheter aortic valve replacement. JACC Cardiovasc Interv. 2016;9(5):472-80. https://
                       linkinghub.elsevier.com/retrieve/pii/S1936879815019251
                   [11] Dua JS, Osborne NJR, Tometzki AJP, Martin RP. Axillary artery approach for balloon

                       valvoplasty in young infants with severe aortic valve stenosis: medium-term results.
                       Catheter Cardiovasc Interv. 2006;68(6): 929-35. http://doi.wiley.com/10.1002/ccd.20909
                   [12] Breatnach CR, Aggarwal V, Al-Alawi K, McMahon CJ, Franklin O, Prendiville T, et al.
                       Percutaneous axillary artery approach for ductal stent-ing in critical right ventricular

                       outflow tract lesions in the neonatal period. Catheter Cardiovasc Interv. 2019;93:1329.
                       https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.28302
                   [13] Levy MJ, Lillehei CW. Percutaneous direct cardiac catheterization. N Engl J Med.
                       1964;271(6):273-80. http://www.nejm.org/doi/abs/10.1056/NEJM196408062710601

                   [14] Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, et al. Transcatheter
                       closure of perimembranous ventricular septal defects using the amplatzer membranous
                       VSD occluder: immediate and midterm results of an international registry. Catheter Car-
                       diovasc Interv. 2006;68(4):620-8. http://doi.wiley.com/10.1002/ccd.20659

                   [15] Michel-Behnke I, Ewert P, Koch A, Bertram H, Emmel M, Fischer G, et al. Device
                       closure of ventricular septal defects by hybrid procedures: a multicenter retrospective
                       study. Catheter Cardiovasc Interv. 2011;77(2):242-51. http://doi.wiley.com/10.1002/
                       ccd.22666

                   [16] Holoshitz N, Ilbawi MN, Amin Z. Perventricular melody valve implantation in a 12
                       kg child. Catheter Cardiovasc Interv. 2013;82(5):824-7. http://doi.wiley.com/10.1002/
                       ccd.25044
                   [17] Zhou Y, Liu L-X, Zhao F, Tang S-H, Peng H-L, Jiang Y-H. Effects of transthoracic
   206   207   208   209   210   211   212   213   214   215   216